Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-20 · accession 0001193125-26-064681 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-23 | 2026-02-20 | AXSM | Coleman Mark | Dir | M - OptEx | $4.95 | +12.5K | 65.9K | +23% | +$61.8K |
| D | 2026-02-23 | 2026-02-20 | AXSM | Coleman Mark | Dir | M - OptEx | $0.00 | -12.5K | 14.0K | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | M | A | 12,485 | $4.95 | 65,890 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-20 | M | D | 12,485 | $0.00 | 13,971 | D | $4.95 · 2018-03-15 to 2027-03-15 | 12,485 Common Stock |